Beijing Leadman Biochemistry Co.,Ltd. (SHE:300289)
China · Delayed Price · Currency is CNY 7.43
+0.15 (2.06%)
Jan 23, 2026, 3:10 PM CST
SHE:300289 Revenue
Beijing Leadman Biochemistry had revenue of 91.76M CNY in the quarter ending September 30, 2025, a decrease of -1.83%. This brings the company's revenue in the last twelve months to 340.65M, down -15.52% year-over-year. In the year 2024, Beijing Leadman Biochemistry had annual revenue of 370.23M, down -19.79%.
Revenue (ttm)
340.65M
Revenue Growth
-15.52%
P/S Ratio
11.87
Revenue / Employee
727.89K
Employees
427
Market Cap
4.04B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 370.23M | -91.33M | -19.79% |
| Dec 31, 2023 | 461.55M | -244.42M | -34.62% |
| Jan 1, 2023 | 705.98M | 141.92M | 25.16% |
| Jan 1, 2022 | 564.06M | 92.55M | 19.63% |
| Dec 31, 2020 | 471.51M | -43.63M | -8.47% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Guangdong Biolight Meditech | 1.05B |
| Getein Biotech | 1.04B |
| Shanghai Kinetic Medical | 1.02B |
| Guangdong Transtek Medical Electronics | 984.77M |
| Zhejiang Orient Gene Biotech | 842.11M |
| Ningbo David Medical Device | 516.76M |
| Dirui Industrial | 511.11M |
| Chison Medical Technologies | 449.62M |